Baijul Pharma Pvt Ltd
About Baijul Pharma Pvt Ltd
Data last updated:
Baijul Pharma Pvt Ltd is a private limited company based in Sarigam, Gujarat, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 10 December 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1992PTC018670. Its GSTIN is 24AAACB9901G1ZZ (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors Hamir Devkrandas Kanani (Whole-Time Director) and Chetna Hamir Kanani.
Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 3109 GIDC Sarigam Estate, Gujarat, India – 396155.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.35 Cr, a growth of 77% compared to the previous year. For the same year it recorded a net profit of ₹3.38 Lakh (net margin 1.4%) and EBITDA of ₹7.32 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh and satisfied charges of ₹5.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Baijul Pharma Pvt Ltd's registered office is in Sarigam, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 3109 GIDC Sarigam Estate, Gujarat, India – 396155
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Baijul Pharma Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Baijul Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Baijul Pharma Pvt Ltd, buy the company report.
Financials of Baijul Pharma Pvt Ltd
FY 2025 filings availableBaijul Pharma Pvt Ltd reported revenue of ₹2.35 Cr (up 77% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 77% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Baijul Pharma Pvt Ltd, buy the company report.
Board of directors of Baijul Pharma Pvt Ltd
Baijul Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hamir Devkrandas Kanani | Whole-Time Director | 10 Mar 2025 | 1 Years 7 Months | Current |
| Chetna Hamir Kanani | Director | 10 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Baijul Pharma Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dhavit Global Life Sciences Private Limited | ₹2.36 Cr (FY 2021) | Solapur, Maharashtra, India | ||||
| Sarabhai M. Chemicals Limited | ₹2.35 Cr (FY 2025) | 14.0% | Ahmedabad, Gujarat, India | |||
| Baijul Pharma Pvt Ltdthis company | ₹2.35 Cr (FY 2025) | ₹3.38 Lakh | 1.4% | 77.0% | Sarigam, Gujarat, India | |
| Espee Formulation Private Limited | ₹2.35 Cr (FY 2025) | -3.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Baijul Pharma Pvt Ltd, buy the company report.
Auditor
Baijul Pharma Pvt Ltd is audited by G B Laddha & Co LLP for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G B Laddha & Co LLP | FY 2017 | 120352W |
Shareholding
The shareholding of Baijul Pharma Pvt Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Baijul Pharma Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Feb 2011 | 10270783 | Development Credit Bank Limited | ₹5 Lakh | Open | |
| 14 Oct 1993 | 90111214 | Development Co. Operative Bank Ltd. | ₹3 Lakh | Satisfied | |
| 20 Sep 1993 | 90109041 | Development Credit Bank Ltd. | ₹2.5 Lakh | Satisfied |
To see the full charge records of Baijul Pharma Pvt Ltd, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Baijul Pharma Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Baijul Pharma Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Baijul Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACB9901G1ZZ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Baijul Pharma Pvt Ltd, buy the company report.
Recent activity
Baijul Pharma Pvt Ltd has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Hamir Devkrandas Kanani was appointed as Whole-Time Director on 10 Mar 2025.
1 earlier event is in the company report.
Frequently asked questions
Baijul Pharma is an active private limited company based in Sarigam, Gujarat, India. The company works in chemical products, within the chemicals industry. It was incorporated on 10 December 1992 (34+ years old) and is registered under CIN U24231GJ1992PTC018670.
Baijul Pharma has 2 current directors:
- Hamir Devkrandas Kanani - Whole-Time Director
- Chetna Hamir Kanani - Director
The latest financial statements of Baijul Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Baijul Pharma is 24AAACB9901G1ZZ, registered in Gujarat.
The CIN (Corporate Identification Number) of Baijul Pharma is U24231GJ1992PTC018670. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baijul Pharma was incorporated on 10 December 1992, making it 34+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Baijul Pharma by revenue are Dhavit Global Life Sciences Private Limited, Sarabhai M. Chemicals Limited, Espee Formulation Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hamir Devkrandas Kanani was appointed as Whole-Time Director on 10 Mar 2025. Shailesh Devkaran Kanani ceased to be Director on 15 Feb 2021. Chetna Hamir Kanani was appointed as Director on 10 Feb 2021. Baijul Pharma has 4 board changes on record in total.
The registered office of Baijul Pharma is at Plot No. 3109 GIDC Sarigam Estate, Gujarat, India – 396155.
Baijul Pharma operates in the chemicals industry, in the chemical products segment.
Baijul Pharma has open charges of ₹5 Lakh and satisfied charges of ₹5.5 Lakh as per latest MCA filings.